- Home
- AME vs TAK Comparison
AME vs TAK Comparison
Compare AME & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AME
- TAK
- Stock Information
- Founded
- AME 1930
- TAK 1781
- Country
- AME United States
- TAK Japan
- Employees
- AME N/A
- TAK N/A
- Industry
- AME Industrial Machinery/Components
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- AME Industrials
- TAK Health Care
- Exchange
- AME Nasdaq
- TAK Nasdaq
- Market Cap
- AME 42.1B
- TAK 47.5B
- IPO Year
- AME N/A
- TAK N/A
- Fundamental
- Price
- AME $176.72
- TAK $13.61
- Analyst Decision
- AME Buy
- TAK
- Analyst Count
- AME 8
- TAK 0
- Target Price
- AME $200.14
- TAK N/A
- AVG Volume (30 Days)
- AME 1.3M
- TAK 3.9M
- Earning Date
- AME 07-31-2025
- TAK 07-30-2025
- Dividend Yield
- AME 0.70%
- TAK 3.99%
- EPS Growth
- AME 7.39
- TAK N/A
- EPS
- AME 6.11
- TAK 0.45
- Revenue
- AME $6,936,971,000.00
- TAK $30,595,075,281.00
- Revenue This Year
- AME $2.53
- TAK $1.01
- Revenue Next Year
- AME $5.00
- TAK $1.04
- P/E Ratio
- AME $28.87
- TAK $62.73
- Revenue Growth
- AME 2.98
- TAK 7.45
- 52 Week Low
- AME $145.02
- TAK $12.80
- 52 Week High
- AME $198.33
- TAK $15.53
- Technical
- Relative Strength Index (RSI)
- AME 43.07
- TAK 27.54
- Support Level
- AME $177.26
- TAK $14.29
- Resistance Level
- AME $180.89
- TAK $14.86
- Average True Range (ATR)
- AME 2.36
- TAK 0.24
- MACD
- AME -0.31
- TAK -0.10
- Stochastic Oscillator
- AME 31.54
- TAK 6.53
About AME AMETEK Inc.
Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns a collection of over 40 autonomous industrial businesses operating within the research, aerospace, energy, medical, and manufacturing industries. Ametek segments its business into two operating groups: the electronic instruments group and the electromechanical group. The EIG sells a broad portfolio of analytical, test, and measurement instruments, while the EMG sells highly engineered components, interconnects, and specialty metals. The company emphasizes product differentiation and market leadership in the niche markets where it operates.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.